Minimally invasive surgery for recurrent cervical or vaginal cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial tests a minimally invasive surgery (using small incisions) to remove a pelvic tumor that has come back after treatment for vaginal or cervical cancer. It aims to see if this approach can safely remove the recurrence while avoiding more extensive surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have vaginal or cervical cancer that has come back (recurred) or not gone away after treatment.
- Your cancer type is one of these: squamous cell carcinoma, adenocarcinoma, or adenosquamous carcinoma (checked under a microscope).
- The recurrence is only in the central part of the pelvis, and the tumor is 5 cm or smaller on an MRI scan.
- You are 18 or older and in good enough health for surgery (with an ECOG performance status of 0, 1, or 2).
- You have not had any other type of cancer in the last 5 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways of removing the cervix and nearby tissue: minimally invasive (smaller incisions) versus open radical hysterectomy (a larger incision). It may help determine which approach works best for early-stage cervical cancer.
This trial tests a minimally invasive surgery (using a stapler) for removing the uterus and cervix in women with early-stage cervical cancer (stage IB2 or IIA1). It aims to see if this approach is safe and effective compared to standard surgery.
This trial tests whether using a small-scope (minimally invasive) surgery instead of a large incision can safely remove remaining ovarian cancer after chemotherapy. It may mean a faster recovery and fewer complications.
This study tests whether a less invasive type of hysterectomy (keyhole surgery) works well for women with very early-stage cervical cancer. It aims to find a safer, faster recovery option for low-risk tumors.
This trial tests how safe a specific minimally invasive surgery tool (an endoscopic stapler) is for people with early-stage cervical cancer. If you qualify, you would get surgery to remove the cervix area using a minimally invasive approach and the study will track safety outcomes.
This trial studies the results of a major surgery called pelvic exenteration for patients with advanced rectal or anal cancer that has spread to nearby tissues or bones but not to distant organs. The goal is to see how well the surgery works and how patients recover afterward.
Hear when a new Cervical Cancers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.